Filing Details
- Accession Number:
- 0001209191-20-063657
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-15 20:51:57
- Reporting Period:
- 2020-12-14
- Accepted Time:
- 2020-12-15 20:51:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1020214 | Cerus Corp | CERS | Surgical & Medical Instruments & Apparatus (3841) | 680262011 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1023259 | Gail Schulze | C/O Cerus Corporation 1220 Concord Ave Concord CA 94520 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-14 | 15,000 | $2.48 | 62,393 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-14 | 15,000 | $7.48 | 47,393 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-14 | 47,393 | $7.27 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2020-12-14 | 15,000 | $0.00 | 15,000 | $2.48 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-01-02 | No | 4 | M | Direct |
Footnotes
- The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.28 to $7.595 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
- The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.25 to $7.325 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
- The option became exercisable in 12 equal monthly installments after the grant date.
- Not applicable.
Billionaire Hedge Funds
